There are at least three promising vaccine candidates. Two are likely to get emergency use authorization in the coming weeks. A third showed promising results, but is facing questions. And more candidates are close behind. We walk you through what you need to know.
- Plus, how news outlets are adjusting to a time after President Donald Trump.
- And, a primer on the social media site Parler.
Guests: Axios' Sam Baker, Sara Fischer and Dan Primack
Credits: "Axios Today" is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Carol Wu, Cara Shillenn, Nuria Marquez Martinez, Dan Bobkoff, Sara Kehaulani Goo, Alex Sugiura and Naomi Shavin. Music is composed by Evan Viola. You can reach us at podcasts@axios.com.
